These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 32567497)

  • 1. Structure-based identification of natural compound inhibitor against
    Lata S; Akif M
    J Biomol Struct Dyn; 2021 Aug; 39(12):4480-4489. PubMed ID: 32567497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of Pleurotin binding to human thioredoxin reductase using docking and molecular dynamics simulation.
    Quintanilha DB; Santos HFD
    J Biomol Struct Dyn; 2023; 41(12):5646-5659. PubMed ID: 35758249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel starting points for fragment-based drug design against mycobacterial thioredoxin reductase identified using crystallographic fragment screening.
    Füsser FT; Wollenhaupt J; Weiss MS; Kümmel D; Koch O
    Acta Crystallogr D Struct Biol; 2023 Sep; 79(Pt 9):857-865. PubMed ID: 37574972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-based virtual screening, molecular dynamics simulation and MM-PBSA toward identifying the inhibitors for two-component regulatory system protein NarL of
    Kumar N; Srivastava R; Prakash A; Lynn AM
    J Biomol Struct Dyn; 2020 Jul; 38(11):3396-3410. PubMed ID: 31422761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of M. tuberculosis thioredoxin reductase inhibitors based on high-throughput docking using constraints.
    Koch O; Jäger T; Heller K; Khandavalli PC; Pretzel J; Becker K; Flohé L; Selzer PM
    J Med Chem; 2013 Jun; 56(12):4849-59. PubMed ID: 23676086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The thioredoxin antioxidant system.
    Lu J; Holmgren A
    Free Radic Biol Med; 2014 Jan; 66():75-87. PubMed ID: 23899494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disruption of redox catalytic functions of peroxiredoxin-thioredoxin complex in Mycobacterium tuberculosis H37Rv using small interface binding molecules.
    Gurung AB; Das AK; Bhattacharjee A
    Comput Biol Chem; 2017 Apr; 67():69-83. PubMed ID: 28063347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ensemble-based high-throughput virtual screening of natural ligands using the Super Natural-II database against cell-wall protein dTDP-4-dehydrorhamnose reductase (RmlD) in
    Ravichandran R; Ridzwan NFW; Mohamad SB
    J Biomol Struct Dyn; 2022 Jul; 40(11):5069-5078. PubMed ID: 33382017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virtual screening to identify novel potential inhibitors for Glutamine synthetase of
    Kumari M; Subbarao N
    J Biomol Struct Dyn; 2020 Oct; 38(17):5062-5080. PubMed ID: 31755360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rv0807, a putative phospholipase A2 of
    Sundar S; Thangamani L; Manivel G; Kumar P; Piramanayagam S
    J Biomol Struct Dyn; 2020 Aug; 38(13):3990-4004. PubMed ID: 31588859
    [No Abstract]   [Full Text] [Related]  

  • 11. Crystal structure of the Plasmodium falciparum thioredoxin reductase-thioredoxin complex.
    Fritz-Wolf K; Jortzik E; Stumpf M; Preuss J; Iozef R; Rahlfs S; Becker K
    J Mol Biol; 2013 Sep; 425(18):3446-60. PubMed ID: 23845423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the interaction mechanism between potential inhibitor and multi-target Mur enzymes of mycobacterium tuberculosis using molecular docking, molecular dynamics simulation, principal component analysis, free energy landscape, dynamic cross-correlation matrices, vector movements, and binding free energy calculation.
    Kumari M; Singh R; Subbarao N
    J Biomol Struct Dyn; 2022; 40(24):13497-13526. PubMed ID: 34662260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carfilzomib as a potential inhibitor of NADH-dependent enoyl-acyl carrier protein reductases of
    Mahfuz AMUB; Stambuk Opazo F; Aguilar LF; Iqbal MN
    J Biomol Struct Dyn; 2022 Jun; 40(9):4021-4037. PubMed ID: 33251968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solution structures of Mycobacterium tuberculosis thioredoxin C and models of intact thioredoxin system suggest new approaches to inhibitor and drug design.
    Olson AL; Neumann TS; Cai S; Sem DS
    Proteins; 2013 Apr; 81(4):675-89. PubMed ID: 23229911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Refined homology model of cytochrome bcc complex B subunit for virtual screening of potential anti-tuberculosis agents.
    Pan Z; Wang Y; Gu X; Wang J; Cheng M
    J Biomol Struct Dyn; 2020 Oct; 38(16):4733-4745. PubMed ID: 31674290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applying the designed multiple ligands approach to inhibit dihydrofolate reductase and thioredoxin reductase for anti-proliferative activity.
    Ng HL; Chen S; Chew EH; Chui WK
    Eur J Med Chem; 2016 Jun; 115():63-74. PubMed ID: 26994844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of peroxides and dinitrobenzenes by Mycobacterium tuberculosis thioredoxin and thioredoxin reductase.
    Zhang Z; Hillas PJ; Ortiz de Montellano PR
    Arch Biochem Biophys; 1999 Mar; 363(1):19-26. PubMed ID: 10049495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug repurposing: Fusidic acid as a potential inhibitor of M. tuberculosis FtsZ polymerization - Insight from DFT calculations, molecular docking and molecular dynamics simulations.
    Akinpelu OI; Lawal MM; Kumalo HM; Mhlongo NN
    Tuberculosis (Edinb); 2020 Mar; 121():101920. PubMed ID: 32279872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein-protein interactions at an enzyme-substrate interface: characterization of transient reaction intermediates throughout a full catalytic cycle of Escherichia coli thioredoxin reductase.
    Negri A; Rodríguez-Larrea D; Marco E; Jiménez-Ruiz A; Sánchez-Ruiz JM; Gago F
    Proteins; 2010 Jan; 78(1):36-51. PubMed ID: 19585660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A thioredoxin reductase and/or thioredoxin system-based mechanism for antioxidant effects of ambroxol.
    Huang J; Xu J; Tian L; Zhong L
    Biochimie; 2014 Feb; 97():92-103. PubMed ID: 24103200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.